MBX vs MGM · $1.98B cap vs P/E 64, rev $4.45B
MBX Biosciences, Inc. Common Stock (MBX) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
MBX does not have a complete income-statement cache yet.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
MBX currently screens at market cap $1.98B. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the MBX and MGM stock pages for the full models.
Not investment advice.